Scope and how to use this reference
This is a working reference for advertising copy about non-surgical fat reduction, body contouring, skin-tightening claims made for the body, and injectable routes presented alongside such treatment. It translates selected requirements in the UK Code of Non-broadcast Advertising and Direct & Promotional Marketing, usually called the CAP Code, into checks that can be applied to a webpage, social post, paid search advert, brochure, leaflet or consultation promotion.
The Advertising Standards Authority, or ASA, applies the CAP Code to non-broadcast advertising. The table records the Code provisions engaged by the types of claim commonly seen in this area. The final column identifies the ASA page where the rule or relevant ASA material is published. Each named page was read on 21 November 2026. A page reference is not evidence that a particular future advert will breach the Code: the ASA assesses the overall presentation, audience, qualifications, images and evidence available for the claim.
The reference deliberately does not translate device marketing into a promise of outcome. A technical description, a study abstract, a supplier statement and a customer's account do different jobs. None removes the advertiser's duty to avoid misleading consumers or to hold substantiation before making an objective claim.
Decision rule: If a reader could take wording, an image, a review or an offer as a promise that treatment will reduce fat, reshape an area, improve a health condition or produce a particular result, treat it as an advertising claim. Check the evidence and the CAP Code before publication, not after a complaint.
This reference concerns UK non-broadcast advertising. Broadcast advertising has separate rules. It is not clinical advice, a device-regulation guide, or a guide to whether a treatment is suitable for an individual.
Rule table: misleading claims, evidence and exaggeration
The core issue is the net impression. Qualifying words do not necessarily cure a prominent claim if the overall message remains broader than the evidence. Evidence should match the precise treatment, protocol, body area, population and outcome being advertised. Claims of fat reduction, contour change or measurable loss are not interchangeable merely because they concern the same part of the body.
| CAP Code rule and heading | What it requires in plain words | Wording or presentation that can fall foul | ASA page, read date |
|---|---|---|---|
| 3.1 Misleading advertising | Advertising must not materially mislead or be likely to do so. The overall impression matters, including omissions and presentation. | Calling a cosmetic body treatment a reliable route to a body-shape outcome without making material limits clear, or using an absolute outcome where results vary. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
| 3.7 Substantiation | Before distributing or submitting an advert, advertisers must hold documentary evidence for objective claims that consumers are likely to regard as capable of objective substantiation. | "Proven to remove fat" or "clinically proven body contouring" where the advertiser cannot produce evidence that supports that exact claim. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
| 3.11 Exaggeration | Advertising must not mislead by exaggerating a product or service's capability or performance. | Describing a non-surgical treatment as a total transformation, a guaranteed solution, or able to achieve a level of change not supported by the evidence. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
A claim can be objective even when it avoids a number. "Melts fat", "permanent contouring", "treats stubborn fat" and "results that dieting cannot achieve" may each communicate testable propositions. The relevant question is not whether the copy sounds scientific. It is what a typical reader is likely to understand it to mean.
Rule table: testimonials, reviews and endorsements
Testimonials can be advertising claims in their own right. Reposting a customer's words, placing a review in an image, or presenting an influencer's experience does not make the advertiser a neutral observer. The advertiser remains responsible for the marketing communication it publishes or controls. A personal account may describe one person's experience, but it cannot safely carry a broader promise that consumers are likely to understand as typical, guaranteed or medically meaningful.
| CAP Code rule and heading | What it requires in plain words | Wording or presentation that can fall foul | ASA page, read date |
|---|---|---|---|
| 3.45 Testimonials and endorsements | Testimonials and endorsements must be genuine, relate to the experience of the person giving them, and not mislead. | A customer quotation presented as proof that a treatment works for everyone, or a statement attributed to a person who did not have the advertised treatment. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
| 3.46 Testimonials and endorsements | Testimonials must not be used in a way that is likely to mislead about the nature or outcome of the advertised product or service. | "I lost inches after one session" used beside a general course offer without context that would prevent readers taking it as an expected outcome. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
Keep a record identifying the author, the date, the treatment actually received and permission to use the material. That record addresses genuineness, but it does not by itself substantiate a wider efficacy claim. If the testimonial makes a health, fat-loss or durable-result proposition, the advertiser still needs appropriate evidence for the impression created.
Do not edit a review so heavily that its meaning changes. Do not imply an ordinary experience when the selection is exceptional. A disclosure may be needed where a commercial connection affects how an endorsement is presented, but a disclosure does not repair a misleading efficacy message.
Before-and-after imagery: the rules applied to pictures
The CAP Code does not create a separate permission for before-and-after imagery. Such imagery is assessed under the misleading advertising and substantiation rules. The ASA's guidance on before-and-after photographs explains why images need to be a fair basis for the comparison claimed. A photograph can communicate an outcome more forcefully than a caption, particularly where it is placed beside terms such as "fat reduction", "contouring" or "real results".
| Rule engaged | Practical check | Risky presentation | ASA page, read date |
|---|---|---|---|
| 3.1 Misleading advertising | Ask whether differences in pose, distance, lighting, camera angle, compression, tanning, clothing or timing could create the apparent result. | A more flattering after image used to suggest a treatment effect that the image cannot reliably demonstrate. | Before and after photos, ASA Advice Online, published by the ASA. Read 21 November 2026. |
| 3.7 Substantiation | Retain material capable of supporting what the comparison is said to show, including the treatment and relevant conditions of capture. | A visual comparison labelled as proof of fat loss when the advertiser cannot support that conclusion. | Misleading advertising, CAP Code Section 3, published by the ASA. Read 21 November 2026. |
Copy beside an image changes the claim. "Individual result" is different from "typical result", but neither phrase makes a misleading image acceptable. A disclaimer also cannot be relied on where the visual presentation conveys a stronger contrary message. If an image has been digitally altered, that can be material to the reader's interpretation and requires especially careful consideration.
For reporting, identify the date, body area, treatment route and any stated result separately. Do not infer fat loss from a narrower-looking waist, and do not infer a treatment effect merely because two photographs are placed together.
Health, beauty and medical language
Body-treatment advertising often moves from an appearance claim into a health claim through a few words: "medical", "therapeutic", "treats", "clinically proven", "safe", "approved" or "diagnoses". The CAP Code's Section 12 applies to medicines, medical devices, health-related products and beauty products. Its requirements sit alongside the general rules in Section 3. A claim can therefore need substantiation and also raise a Section 12 issue.
| CAP Code rule and heading | What it requires in plain words | Wording or presentation that can fall foul | ASA page, read date |
|---|---|---|---|
| 12.1 Medicines, medical devices, health-related products and beauty products | Claims must be made responsibly and must not discourage essential treatment for conditions for which medical supervision should be sought. | Presenting a cosmetic body treatment as an alternative to medical assessment or as treatment for a condition needing medical supervision. | Medicines, medical devices, health-related products and beauty products, CAP Code Section 12, published by the ASA. Read 21 November 2026. |
| 12.2 Medicines, medical devices, health-related products and beauty products | Advertising must not discourage essential treatment for conditions for which medical supervision should be sought. | Copy suggesting that a body treatment can replace a clinician's assessment or management of a medical concern. | Medicines, medical devices, health-related products and beauty products, CAP Code Section 12, published by the ASA. Read 21 November 2026. |
Terms that sound regulatory are not decoration. An advertiser should be able to identify what a term means, which product or service it describes, and why the wording is not liable to mislead. Avoid turning a treatment's cosmetic purpose into an implied diagnosis, disease treatment or medical outcome. Equally, do not suggest that a body concern is a medical disorder merely to increase urgency.
Injectables and prescription-only medicine advertising
Where an injectable route is discussed, identify whether the proposed message advertises a named or identifiable prescription-only medicine, or a prescription-only medical treatment, to the public. The rule is a prohibition, not a wording exercise. Avoiding a brand name does not necessarily settle the question if the public-facing communication still promotes the prescription-only treatment.
| CAP Code rule and heading | What it requires in plain words | Wording or presentation that can fall foul | ASA page, read date |
|---|---|---|---|
| 12.18 Prescription-only medicines and prescription-only medical treatments | Prescription-only medicines or prescription-only medical treatments may not be advertised to the public. | A public post encouraging bookings for an identifiable prescription-only injectable medicine or promoting its expected cosmetic outcome. | Medicines, medical devices, health-related products and beauty products, CAP Code Section 12, published by the ASA. Read 21 November 2026. |
This does not mean every reference to injections is automatically a breach. It means classification and the nature of the public-facing promotion matter. The safe editorial approach is to separate factual discussion of the rule from promotional invitations, efficacy promises, inducements or testimonials for a prescription-only medicine or prescription-only medical treatment.
Do not use a consultation as a label that masks a public advert for a prohibited product or treatment. A consultation can be a service, but the surrounding copy, images and calls to action determine the message consumers receive. Where status is uncertain, obtain specialist regulatory advice before publication rather than relying on a softened description.
Copy check before publication
- Mark every outcome claim. Include headlines, captions, images, testimonials, hashtags, buttons and comparison graphics. Ask what each element tells a typical reader.
- Match evidence to wording. Check that documentary evidence supports the exact treatment, outcome, user group and conditions claimed. If it does not, remove or narrow the claim.
- Test the overall impression. Read the advert without its small print. Does the dominant message promise more than the evidence supports?
- Audit images as claims. Record whether before-and-after images are comparable and whether their presentation could create an artificial difference.
- Verify testimonials. Keep proof they are genuine and accurately represent the contributor's experience. Do not convert an individual account into a general result claim.
- Separate appearance from health. Remove language that implies diagnosis, treatment of a medical condition or replacement of essential medical care unless it is justified and compliant.
- Screen injectable copy. If a prescription-only medicine or prescription-only medical treatment may be identifiable, do not advertise it to the public.
- Keep an audit file. Save the final advert, evidence, image originals, permissions and the date of the review. This makes later scrutiny possible.
Limits of this reference
This reference does not decide whether an individual treatment works, is safe, is suitable, is a medical device, or may lawfully be supplied. It does not cover surgical liposuction, nor does it provide a route around rules governing medicinal products, professional practice, consumer contracts, data protection or image consent. It also does not replace a reading of the current CAP Code and relevant ASA rulings.
It applies to UK non-broadcast advertising aimed at consumers. Different rules and bodies may apply to broadcast advertising, professional-to-professional material, packaging, editorial content not under an advertiser's control, or communications outside the UK. The Code provisions and ASA guidance can change. The page-read date in each table row is therefore part of the reference, not a claim that the text will remain unchanged.
A complaint outcome depends on the specific advert and the evidence available at the time. Where a claim is complex, concerns an injectable route, or relies on technical clinical material, copy should be reviewed by someone able to assess both the evidence and the advertising context before it goes live.